| Date |
Event |
Presentation |
Speakers |
|
February 2, 2014
|
Developmental Pathways and Cancer: Wnt, Notch and Hedgehog (J7)
|
Cancer in Context: The Microenvironment and Metastasis Registered attendees can view abstracts starting on 01/02/2014
|
Manuel Valiente-Cortes
|
|
January 12, 2014
|
Gordon Research Conference: Glycolipid & Sphingolipid Biology
|
Richard Kolesnick (Sloan-Kettering Cancer Center, USA) "Introduction: Key Issues & Questions"
|
Richard Kolesnick
|
|
|
|
Translational Studies and Therapeutics: Sphingosine-1-Phosphate
|
Richard Kolesnick
|
|
November 21, 2013
|
Cell Symposia: Using Stem Cells to Model and Treat Human Disease
|
Induced aging for iPSC-based modeling of late-onset disease
|
Lorenz Studer
|
|
September 15, 2013
|
ISSCR Regional Forum - Stem Cells in Translation
|
Refreshment Break
|
Lorenz Studer
|
|
May 31, 2013
|
ASCO Annual Meeting 2013
|
Multimodality Approaches to Achieving Tobacco Cessation in the Oncology Practice
|
Jamie S. Ostroff
|
|
|
|
Optimizing the Role of Advanced Practice Professionals in Oncology Practice
|
Dean Bajorin
|
|
|
|
Prostate Cancer Screening: Past, Present, and Future
|
Peter T Scardino, Ethan M. Basch
|
|
|
|
Relating to Patients on a Humanistic or Spiritual Level: How Physicians Can Make a Difference (M01)
|
Jimmie C Holland
|
|
|
|
More Mastectomies: Why? (C05)
|
Monica Morrow
|
|
|
|
Multiplex Genetic Testing for Inherited Cancer Risk: Pros and Cons
|
Mark Robson
|
|
|
|
Optimizing Locoregional Treatment in Early-Stage Breast Cancer
|
Hiram S. Cody
|
|
|
|
Education Sessions
|
Robert G Maki, Leonard Saltz
|
|
|
|
Education Sessions
|
Ethan M. Basch
|
|
|
|
Education Sessions
|
Kenneth Offit
|
|
|
|
Education Sessions
|
Andrew David Zelenetz, Stuart M Lichtman, Sergio Giralt
|
|
|
|
Special Session
|
Teresa Gilewski
|
|
April 6, 2013
|
AACR Annual Meetings
|
CANCER EVOLUTION AND RESISTANCE
|
Neal Rosen
|
|
|
|
Cross-Species Analysis of Mouse and Human Cancer Chairperson: David J. Adams, Wellcome Trust Sanger Institute, Cambridge, United Kingdom
|
Hans-Guido Wendel
|
|
|
|
Building on the Success of CTLA-4 Blockade Through Biomarker Analyses and Development of Novel Combinatorial Strategies Chairperson: Jedd D. Wolchok, Memorial Sloan-Kettering Cancer Center, New York, NY
|
Jedd D. Wolchok, Margaret Callahan
|
|
|
|
Use of Next-Generation Sequencing: Implementation of Clinical Genomics Chairperson: David B. Solit, Memorial Sloan-Kettering Cancer Center, New York, NY
|
David B. Solit
|
|
|
|
Structural Aberrations in a Thousand Tumors Chairperson: Raju Kucherlapati, Harvard Medical School, Boston, MA
|
Chris Sander
|
|
|
|
The Molecular Basis for Improvement in Endometrial Cancer Therapy Co-Chairpersons: Cheryl Lyn Walker, Texas A&M University Health Science Center, Houston, TX, and Douglas A. Levine, Memorial Sloan-Kettering Cancer Center, New York, NY
|
Douglas A. Levine
|
|
|
|
Using Genomics to Guide Cancer Immunotherapy Chairperson: Robert D. Schreiber, Washington University School of Medicine, St. Louis, MO
|
James P Allison
|
|
|
|
Novel Therapeutic Concepts with Kinases, Immuno-, and Radiotherapy Chairperson: Charles L. Sawyers, Memorial Sloan-Kettering Cancer Center, New York, NY
|
James A. Fagin
|
|
|
|
Predictive Modeling of Cancer Treatment in Single Patients (N of 1) Moderator: Charles L. Sawyers, Memorial Sloan-Kettering Cancer Center, New York, NY
|
David B. Solit
|
|
|
|
Clinical Trials Based on Mutations versus Histology
|
Charles L Sawyers
|
|
|
|
Credentialing Response Biomarkers for Signal Transduction Inhibitors Chairperson: Neal Rosen, Memorial Sloan-Kettering Cancer Center, New York, NY
|
Neal Rosen
|
|
|
|
Noncoding RNAs in Cancer: From Pathogenesis to Therapeutics Chairperson: Elsa R. Flores, The University of Texas MD Anderson Cancer Center, Houston, TX
|
Andrea Ventura
|
|
|
|
Tumor-Secreted Factors Chairperson: David C. Lyden, Weill Cornell Medical College of Cornell University, New York, NY
|
David C Lyden
|
|
|
|
Progress in Targeting Chromatin Modifying Enzymes in Cancer Therapy Victoria M. Richon, Sanofi Oncology, Cambridge, MA
|
Victoria M. Richon
|
|
|
|
Macrophages as a Therapeutic Target in the Tumor Microenvironment Johanna A. Joyce, Memorial Sloan-Kettering Cancer Center, New York, NY
|
Johanna A. Joyce
|
|
January 20, 2013
|
Tumor Invasion and Metastasis
|
Macrophages as a therapeutic target in invasive gliomas
|
Johanna A Joyce
|
|
|
|
Niches and pathways of latent and overt metastasis
|
Joan Massagué
|
|
|
|
Session 4: Metastasis Signaling Pathways
|
Joan Massagué
|
|
February 22, 2012
|
The SRS/SBRT Scientific Meeting - 2012
|
SBRT and Other Therapeutic Approaches for Clinically Localized Prostate Cancer
|
Michael J Zelefsky
|
|
October 10, 2011
|
15th Annual Meeting Collaborative Group of the Americas, on Inherited Colorectal Cancer (CGA-ICC)
|
Management of Rectal and Pouch Polyposis
|
Jose Guillem
|
|
August 21, 2011
|
The TGF-β Superfamily: Signaling in Development and Disease
|
A Smad epigenetic switch in stem cell regulation
|
Joan Massagué
|
|
|
|
Session 9 | TGFβ signaling and Stem cell regulation
|
Joan Massagué
|
|
May 26, 2011
|
Idibell Cancer Conference on Metastasis and Angiogenesis
|
The tumor microenvironment in cancer progression and response to therapy
|
Johanna A Joyce
|
|
March 9, 2011
|
28th Annual Miami Breast Cancer Conferenceâ„¢
|
Hereditary Breast Cancers
|
Mark Robson
|
|
|
|
Occult Carcinoma
|
Hiram S. Cody
|
|
|
|
Predisposition Syndromes Associated With Breast Cancer
|
Mark Robson
|
|
|
|
How to Do a Sentinel Node Biopsy: Axillary Dissections and Internal Mammary Biopsy
|
Hiram S. Cody
|
|
|
|
Sessions 3 | "Meet the Professor" Sessions
|
Mark Robson
|
|
|
|
Session A | Prophylactic Contralateral Mastectomy: Current Recommendations, Technique, and Outcome
|
Hiram S. Cody
|
|
March 6, 2011
|
Stem Cells, Cancer and Metastasis (C4)
|
Priming the Soil: The Pre-Metastatic Niche
|
David C Lyden
|
|
February 27, 2011
|
AACR-NCI Conference on Systems Biology: Confronting the Complexity of Cancer
|
Session 4 | Cancer Stem Cells/Developmental Biology
|
Franziska Michor
|
|
February 17, 2011
|
15th Annual International Congress on Hematologic Malignancies: Focus on Leukemias, Lymphomas, and Myeloma
|
Overall Survival
|
Andrew D. Zelenetz, MD, PhD
|
|
|
|
Welcome
|
Andrew D. Zelenetz, MD, PhD
|
|
|
|
Do New Therapies Change the Paradigm for Treatment of Peripheral T-Cell Lymphoma?
|
Steven Horwitz
|
|
|
|
Comment
|
Steven Horwitz
|
|
|
|
Myeloproliferative Neoplasms
|
Martin S. Tallman
|
|
|
|
Can Acute Promyelocytic Leukemia Be Managed Without Chemotherapy?
|
Martin S. Tallman
|
|
|
|
Afternoon Workshop | Monoclonal Antibodies
|
Andrew D. Zelenetz, MD, PhD
|
|
|
|
Supportive Care in Hematologic Malignancies
|
Andrew D. Zelenetz, MD, PhD
|
|
|
|
Lymphoma
|
Steven Horwitz
|
|
|
|
Chronic Lymphocytic Leukemia
|
Andrew D. Zelenetz, MD, PhD
|
|
|
|
Tumor Boards | Challenging Cases in Hematologic Malignancies and Attendee-Submitted Cases
|
Andrew David Zelenetz
|
|
December 8, 2010
|
33rd Annual CTRC-AACR San Antonio Breast Cancer Symposium
|
Challenges to clinical application of new discoveries in the genetics of breast cancer predisposition
|
Mark Robson
|
|
|
|
The Clinical Utility of Genetic Testing for Inherited Predisposition to Breast Cancer: BRCA and Beyond | Ballroom C-2
|
Mark Robson
|
|
October 20, 2010
|
6th Annual Meeting of the Oligonucleotide Therapeutics Society
|
Control of 3´UTR length by alternative cleavage and polyadenylation and its role in human cancer
|
Christine Mayr
|
|
September 12, 2010
|
Joint Metastasis Research Society-AACR Conference in Conjunction with the Tumor Microenvironment Working Group of the AACR
|
The pre-metastatic niche: Adapting the foreign soil
|
David C Lyden
|
|
|
|
Plenary Session 1: The Influence of the Niche
|
David C Lyden
|
|
|
|
Metastasis meets microenvironment
|
Joan Massagué
|
|
|
|
Plenary Session 3: Novel Molecular Pathways
|
Joan Massagué
|
|
May 26, 2010
|
International Symposium Stem Cells in Biology & Disease
|
SESSION 5: Technological advances in manipulating pluripotent stem cells
|
Lorenz Studer
|
|
May 19, 2010
|
Towards Personalized Cancer Medicine
|
Deconstructing Metastasis
|
Joan Massagué
|
|
|
|
SESSION I: Biology (Processes Leading to Cancer)
|
Joan Massagué
|
|
|
|
Closing Remarks
|
Joan Massagué
|
|
|
|
Immune Checkpoint Blockade in Cancer Therapy
|
James P Allison
|
|
May 12, 2010
|
Stem Cells, Tissue Homeostasis and Cancer
|
Stem Cells in Tissue Homeostasis and Regeneration | Lorenz Studer
|
Lorenz Studer
|
|
October 1, 2009
|
6TH ANNUAL MEETING OF THE INTERNATIONAL SOCIETY OF GASTROINTESTINAL ONCOLOGY (ISGIO)
|
Panel Discussion With Interactive Q/A
|
Leonard Saltz
|
|
|
|
Treatment of Incurable Metatstatic Colorectal Cancer
|
Leonard Saltz
|
|
|
|
Panel Discussion With Interactive Q/A
|
Nabil Rizk
|
|
|
|
Sparing Esophagus in Patients with Esophageal Cancer
|
Nabil Rizk
|
|
January 5, 2009
|
High Content Analysis
|
Implementation of HCA for Chemical Screening: Applications to Anti-Viral and Stem Cell Modulators Discovery
|
Hakim Djaballah
|
|
December 11, 2008
|
SAN ANTONIO BREAST CANCER SYMPOSIUM
|
Deconstructing Metastasis
|
Joan Massagué
|
|
December 7, 2008
|
AMERICAN SOCIETY FOR MATRIX BIOLOGY 2008 Meeting
|
Concurrent J: Merlin Blocks Tumorigenesis by Inhibiting a Nuclear E3 Ligase
|
Filippo , Giancotti
|
|
November 22, 2008
|
Collaborative Ependymoma Research Network (CERN)
|
CD133+ Expression In The Brain And High-Grade Glioma Of A Mouse Model With A lacZ Reporter Knock-In At The CD133 Locus.
|
Adilia Hormigo
|
|
|
|
YKL-40 And Matrix Metalloproteinase-9 (MMP-9) As Serum Tumor Markers In Gliomas.
|
Fabio Iwamoto
|
|
June 11, 2008
|
6th ISSCR Annual Meeting
|
Session III C: Cell Cycle Regulation & Signaling
|
Kathryn V. Anderson
|
|
|
|
CILIA AND DEVELOPMENTAL SIGNALING
|
Kathryn V. Anderson
|
|
May 30, 2008
|
ASCO Annual'08 Meeting
|
general oncology sessions-- The Growing Challenge of CNS Metastases: New Therapeutic Approaches
|
Lauren E. Abrey
|
|
|
|
general oncology sessions-- Integrating the Humanistic and Scientific Aspects of Patient Care: The Perspective of Seasoned Surgical, Medical, Pediatric, and Radiation Oncologists
|
Teresa Gilewski
|
|
|
|
breast cancer-- Chemotherapy-Induced Cognitive Impairment (M06)
|
Tim A Ahles
|
|
|
|
central nervous system tumors-- Chemotherapy-Induced Cognitive Impairment (M06)
|
Tim A Ahles
|
|
|
|
central nervous system tumors-- The Growing Challenge of CNS Metastases: New Therapeutic Approaches
|
Lauren E. Abrey
|
|
|
|
clinical trials-- Patient-Reported Outcomes in Oncology
|
Ethan M. Basch
|
|
|
|
gynecologic cancer-- Benefit of Multimodality Management of Advanced Sarcoma: Why the Medical Oncologist Should Not Work Alone
|
Murray F. Brennan
|
|
|
|
head and neck cancer-- Physiologic Response Imaging in Head and Neck Cancer
|
Clifton Ling
|
|
|
|
health services research-- Patient-Reported Outcomes in Oncology
|
Ethan M. Basch
|
|
|
|
lymphoma and plasma cell disorders-- Prognosis, Risk Stratification, and Treatment of Diffuse Large B-Cell Lymphoma: Incorporation of New Imaging Modalities and Molecular Markers (CPO11A)
|
Andrew David Zelenetz
|
|
|
|
lymphoma and plasma cell disorders-- Prognosis, Risk Stratification, and Treatment of Diffuse Large B-Cell Lymphoma: Incorporation of New Imaging Modalities and Molecular Markers (CPO11B)
|
Andrew David Zelenetz
|
|
|
|
patient and survivor care-- Patient-Reported Outcomes in Oncology
|
Ethan M. Basch
|
|
|
|
patient and survivor care-- Integrating the Humanistic and Scientific Aspects of Patient Care: The Perspective of Seasoned Surgical, Medical, Pediatric, and Radiation Oncologists
|
Teresa Gilewski
|
|
|
|
professional development-- Integrating the Humanistic and Scientific Aspects of Patient Care: The Perspective of Seasoned Surgical, Medical, Pediatric, and Radiation Oncologists
|
Teresa Gilewski
|
|
|
|
sarcoma/bone and soft tissue cancers-- Benefit of Multimodality Management of Advanced Sarcoma: Why the Medical Oncologist Should Not Work Alone
|
Murray F. Brennan
|
|
|
|
tumor biology-- Physiologic Response Imaging in Head and Neck Cancer
|
Clifton Ling
|
|
|
|
meet the professor sessions-- Chemotherapy-Induced Cognitive Impairment (M06)
|
Tim A Ahles
|
|
|
|
clinical problems in oncology-- Prognosis, Risk Stratification, and Treatment of Diffuse Large B-Cell Lymphoma: Incorporation of New Imaging Modalities and Molecular Markers (CPO11A)
|
Andrew David Zelenetz
|
|
|
|
clinical problems in oncology-- Prognosis, Risk Stratification, and Treatment of Diffuse Large B-Cell Lymphoma: Incorporation of New Imaging Modalities and Molecular Markers (CPO11B)
|
Andrew David Zelenetz
|
|
February 11, 2008
|
Stem Cells World Congress
|
High Content Screening of Human Embryonic Stem Cells: Implications in Novel Neurodegenerative and Cancer Therapies
|
Hakim Djaballah
|
|
January 18, 2008
|
Translational Research Program Stem Cell Symposium
|
RADIATION RESISTANCE/TARGETING STEM CELL PATHWAYS
|
Dolores Hambardzumyan
|
|
December 5, 2007
|
Sixth Annual International Conference on Frontiers in Cancer Prevention Research
|
PLENARY SESSION I - PREDICTING CANCER RISK: ADVANCES IN GENETICS, BIOMARKERS, AND BEHAVIORAL SCIENCE
|
Kenneth Offit
|
|
December 1, 2007
|
47TH American Socieity of Cell Biology
|
Getting In Shape: New Clues From the Fly Embryo
|
Jennifer A Zallen
|
|
|
|
Interphase and Mitotic CDKs Follow Kinetically Distinct Paths to Activation in Human Cells.
|
S. Larochelle, R P Fisher
|
|
|
|
The Cell Biology of Embryonic Patterning and Morphogenesis in the Mouse Embryo
|
Kathryn V. Anderson, Josh Bloomekatz, Isabelle Migeotte
|
|
|
|
Binding of the HBV X Protein to hBubR1 Disturbs the Mitotic Checkpoint and Increases Chromosome Instability
|
Jeff Lee
|
|
|
|
Polarized Cell Behavior during Axis Elongation in Drosophila.
|
Jennifer A Zallen, J Blankenship, J S P. Sanny, O Weitz
|
|
November 7, 2007
|
Srial II: Advances and Challenges Toward Major Diseases: Extension on New Hope Nov (07-13)
|
Session 6: New & Emerging Biomarkers & Drug Targets (09:00-12:00)
|
Anh Tuan Phan
|
|
|
|
Session 6: G-quadruplex Structures of Nucleic Acids as Potential Targets for Drug Design (11:00-11:20)
|
Anh Tuan Phan
|
|
November 4, 2007
|
AACR Centennial Conference: Translational Cancer Medicine
|
Concurrent Session 1: Clinical Pharmacogenetics: Assessing Global Diversity
|
Eric C Lai
|
How We Rank